Global and Region Exosome Diagnostic and Therapeutic Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Exosomes are cell-derived vesicles that are present in many and perhaps all eukaryotic fluids, including blood, urine and cultured medium of cell cultures.

    The report details the trend, potential and market size of Exosome Diagnostic and Therapeutic market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Exosome Diagnostic and Therapeuticmarket, defines the market attractiveness level of Exosome Diagnostic and Therapeutic market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Exosome Diagnostic and Therapeutic industry, describes the types of Exosome Diagnostic and Therapeutic market, the applications of major players and the market size, and deeply analyzes the current situation of the global Exosome Diagnostic and Therapeutic market and the development prospects and opportunities of Exosome Diagnostic and Therapeutic industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Exosome Diagnostic and Therapeutic market in Chapter 13.

    By Player:

    • Thermo Fisher Scientific Inc

    • Aethlon Medical, Inc

    • System Biosciences Inc

    • Sistemic Inc

    • Exosome Diagnostics Inc

    • Capricor Therapeutics

    • NanoSomix Inc

    • Malvern Instruments Ltd

    • NX Pharmagen

    • Exiqon A/S

    By Type:

    • Instrument

    • Reagent

    • Software

    By End-User:

    • Cancer Institute

    • Hospital

    • Diagnostic Center

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Exosome Diagnostic and Therapeutic Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Exosome Diagnostic and Therapeutic Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Exosome Diagnostic and Therapeutic Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Exosome Diagnostic and Therapeutic Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Exosome Diagnostic and Therapeutic Market Analysis and Outlook to 2022

    • 7.1 Global Exosome Diagnostic and Therapeutic Consumption (2017-2022)

    • 7.2 United States Exosome Diagnostic and Therapeutic Consumption (2017-2022)

    • 7.3 Europe Exosome Diagnostic and Therapeutic Consumption (2017-2022)

    • 7.4 China Exosome Diagnostic and Therapeutic Consumption (2017-2022)

    • 7.5 Japan Exosome Diagnostic and Therapeutic Consumption (2017-2022)

    • 7.6 India Exosome Diagnostic and Therapeutic Consumption (2017-2022)

    • 7.7 South Korea Exosome Diagnostic and Therapeutic Consumption (2017-2022)

    8 Region and Country-wise Exosome Diagnostic and Therapeutic Market Analysis and Outlook to 2028

    • 8.1 Global Exosome Diagnostic and Therapeutic Consumption Forecast (2022-2028)

    • 8.2 United States Exosome Diagnostic and Therapeutic Consumption Forecast (2022-2028)

    • 8.3 Europe Exosome Diagnostic and Therapeutic Consumption Forecast (2022-2028)

    • 8.4 China Exosome Diagnostic and Therapeutic Consumption Forecast (2022-2028)

    • 8.5 Japan Exosome Diagnostic and Therapeutic Consumption Forecast (2022-2028)

    • 8.6 India Exosome Diagnostic and Therapeutic Consumption Forecast (2022-2028)

    • 8.7 South Korea Exosome Diagnostic and Therapeutic Consumption Forecast (2022-2028)

    9 Global Exosome Diagnostic and Therapeutic Market Outlook by Types and Applications to 2022

    • 9.1 Global Exosome Diagnostic and Therapeutic Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Instrument Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Reagent Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Software Consumption and Growth Rate (2017-2022)

    • 9.2 Global Exosome Diagnostic and Therapeutic Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Cancer Institute Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Diagnostic Center Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Exosome Diagnostic and Therapeutic Market Outlook by Types and Applications to 2028

    • 10.1 Global Exosome Diagnostic and Therapeutic Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Instrument Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Reagent Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Software Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Exosome Diagnostic and Therapeutic Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Cancer Institute Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Diagnostic Center Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Exosome Diagnostic and Therapeutic Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Exosome Diagnostic and Therapeutic Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Exosome Diagnostic and Therapeutic Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Exosome Diagnostic and Therapeutic Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Exosome Diagnostic and Therapeutic Market Competitive Analysis

    • 14.1 Thermo Fisher Scientific Inc

      • 14.1.1 Thermo Fisher Scientific Inc Company Details

      • 14.1.2 Thermo Fisher Scientific Inc Exosome Diagnostic and Therapeutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Thermo Fisher Scientific Inc Exosome Diagnostic and Therapeutic Product and Service

    • 14.2 Aethlon Medical, Inc

      • 14.2.1 Aethlon Medical, Inc Company Details

      • 14.2.2 Aethlon Medical, Inc Exosome Diagnostic and Therapeutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Aethlon Medical, Inc Exosome Diagnostic and Therapeutic Product and Service

    • 14.3 System Biosciences Inc

      • 14.3.1 System Biosciences Inc Company Details

      • 14.3.2 System Biosciences Inc Exosome Diagnostic and Therapeutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 System Biosciences Inc Exosome Diagnostic and Therapeutic Product and Service

    • 14.4 Sistemic Inc

      • 14.4.1 Sistemic Inc Company Details

      • 14.4.2 Sistemic Inc Exosome Diagnostic and Therapeutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Sistemic Inc Exosome Diagnostic and Therapeutic Product and Service

    • 14.5 Exosome Diagnostics Inc

      • 14.5.1 Exosome Diagnostics Inc Company Details

      • 14.5.2 Exosome Diagnostics Inc Exosome Diagnostic and Therapeutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Exosome Diagnostics Inc Exosome Diagnostic and Therapeutic Product and Service

    • 14.6 Capricor Therapeutics

      • 14.6.1 Capricor Therapeutics Company Details

      • 14.6.2 Capricor Therapeutics Exosome Diagnostic and Therapeutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Capricor Therapeutics Exosome Diagnostic and Therapeutic Product and Service

    • 14.7 NanoSomix Inc

      • 14.7.1 NanoSomix Inc Company Details

      • 14.7.2 NanoSomix Inc Exosome Diagnostic and Therapeutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 NanoSomix Inc Exosome Diagnostic and Therapeutic Product and Service

    • 14.8 Malvern Instruments Ltd

      • 14.8.1 Malvern Instruments Ltd Company Details

      • 14.8.2 Malvern Instruments Ltd Exosome Diagnostic and Therapeutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Malvern Instruments Ltd Exosome Diagnostic and Therapeutic Product and Service

    • 14.9 NX Pharmagen

      • 14.9.1 NX Pharmagen Company Details

      • 14.9.2 NX Pharmagen Exosome Diagnostic and Therapeutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 NX Pharmagen Exosome Diagnostic and Therapeutic Product and Service

    • 14.10 Exiqon A/S

      • 14.10.1 Exiqon A/S Company Details

      • 14.10.2 Exiqon A/S Exosome Diagnostic and Therapeutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Exiqon A/S Exosome Diagnostic and Therapeutic Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Exosome Diagnostic and Therapeutic

    • Figure Exosome Diagnostic and Therapeutic Picture

    • Table Global Exosome Diagnostic and Therapeutic Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Exosome Diagnostic and Therapeutic Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Exosome Diagnostic and Therapeutic Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Exosome Diagnostic and Therapeutic Consumption by Country (2017-2022)

    • Figure United States Exosome Diagnostic and Therapeutic Consumption and Growth Rate (2017-2022)

    • Table Europe Exosome Diagnostic and Therapeutic Consumption and Growth Rate (2017-2022)

    • Figure China Exosome Diagnostic and Therapeutic Consumption and Growth Rate (2017-2022)

    • Figure Japan Exosome Diagnostic and Therapeutic Consumption and Growth Rate (2017-2022)

    • Figure India Exosome Diagnostic and Therapeutic Consumption and Growth Rate (2017-2022)

    • Figure South Korea Exosome Diagnostic and Therapeutic Consumption and Growth Rate (2017-2022)

    • Figure Global Exosome Diagnostic and Therapeutic Consumption Forecast by Country (2022-2028)

    • Figure United States Exosome Diagnostic and Therapeutic Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Exosome Diagnostic and Therapeutic Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Exosome Diagnostic and Therapeutic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Exosome Diagnostic and Therapeutic Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Exosome Diagnostic and Therapeutic Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Exosome Diagnostic and Therapeutic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Instrument Consumption and Growth Rate (2017-2022)

    • Figure Global Reagent Consumption and Growth Rate (2017-2022)

    • Figure Global Software Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Institute Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic Center Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Instrument Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Reagent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Software Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Institute Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic Center Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Exosome Diagnostic and Therapeutic Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Exosome Diagnostic and Therapeutic Export by Region (Top 5 Countries) (2017-2028)

    • Table Thermo Fisher Scientific Inc (Foundation Year, Company Profile and etc.)

    • Table Thermo Fisher Scientific Inc Exosome Diagnostic and Therapeutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific Inc Exosome Diagnostic and Therapeutic Product and Service

    • Table Aethlon Medical, Inc (Foundation Year, Company Profile and etc.)

    • Table Aethlon Medical, Inc Exosome Diagnostic and Therapeutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aethlon Medical, Inc Exosome Diagnostic and Therapeutic Product and Service

    • Table System Biosciences Inc (Foundation Year, Company Profile and etc.)

    • Table System Biosciences Inc Exosome Diagnostic and Therapeutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table System Biosciences Inc Exosome Diagnostic and Therapeutic Product and Service

    • Table Sistemic Inc (Foundation Year, Company Profile and etc.)

    • Table Sistemic Inc Exosome Diagnostic and Therapeutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sistemic Inc Exosome Diagnostic and Therapeutic Product and Service

    • Table Exosome Diagnostics Inc (Foundation Year, Company Profile and etc.)

    • Table Exosome Diagnostics Inc Exosome Diagnostic and Therapeutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Exosome Diagnostics Inc Exosome Diagnostic and Therapeutic Product and Service

    • Table Capricor Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Capricor Therapeutics Exosome Diagnostic and Therapeutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Capricor Therapeutics Exosome Diagnostic and Therapeutic Product and Service

    • Table NanoSomix Inc (Foundation Year, Company Profile and etc.)

    • Table NanoSomix Inc Exosome Diagnostic and Therapeutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table NanoSomix Inc Exosome Diagnostic and Therapeutic Product and Service

    • Table Malvern Instruments Ltd (Foundation Year, Company Profile and etc.)

    • Table Malvern Instruments Ltd Exosome Diagnostic and Therapeutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Malvern Instruments Ltd Exosome Diagnostic and Therapeutic Product and Service

    • Table NX Pharmagen (Foundation Year, Company Profile and etc.)

    • Table NX Pharmagen Exosome Diagnostic and Therapeutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table NX Pharmagen Exosome Diagnostic and Therapeutic Product and Service

    • Table Exiqon A/S (Foundation Year, Company Profile and etc.)

    • Table Exiqon A/S Exosome Diagnostic and Therapeutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Exiqon A/S Exosome Diagnostic and Therapeutic Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.